ES2106680A1 - Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondiente. - Google Patents

Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondiente.

Info

Publication number
ES2106680A1
ES2106680A1 ES09501578A ES9501578A ES2106680A1 ES 2106680 A1 ES2106680 A1 ES 2106680A1 ES 09501578 A ES09501578 A ES 09501578A ES 9501578 A ES9501578 A ES 9501578A ES 2106680 A1 ES2106680 A1 ES 2106680A1
Authority
ES
Spain
Prior art keywords
ciprofloxacine
compositions containing
aqueous compositions
related use
rest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09501578A
Other languages
English (en)
Other versions
ES2106680B1 (es
Inventor
Soler Pedro Canovas
Rueda Juan Moreno
Duarte Joaquin Antonio Delgado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayvit SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES09501578A priority Critical patent/ES2106680B1/es
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES96924896T priority patent/ES2205048T3/es
Priority to US08/809,622 priority patent/US5786363A/en
Priority to DE69629664T priority patent/DE69629664T2/de
Priority to JP50814597A priority patent/JP4081521B2/ja
Priority to PT96924896T priority patent/PT806206E/pt
Priority to SI9630651T priority patent/SI0806206T1/xx
Priority to EP96924896A priority patent/EP0806206B1/en
Priority to AU65201/96A priority patent/AU701697B2/en
Priority to CA002200760A priority patent/CA2200760C/en
Priority to AT96924896T priority patent/ATE247962T1/de
Priority to DK96924896T priority patent/DK0806206T3/da
Priority to RU97107154/14A priority patent/RU2165755C2/ru
Priority to PCT/ES1996/000155 priority patent/WO1997005880A1/es
Publication of ES2106680A1 publication Critical patent/ES2106680A1/es
Application granted granted Critical
Publication of ES2106680B1 publication Critical patent/ES2106680B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

COMPOSICIONES ACUOSAS CONTENIENDO CIPROFLOXACINO, Y UTILIZACION Y PROCEDIMIENTO CORRESPONDIENTES; LAS COMPOSICIONES COMPRENDEN; DE 0,12 A 0,6 G/100 ML DE CLORHIDRATO MONOHIDRATO DE CIPROFLOXACINO (EQUIVALENTE A 0,1-0,5% DE BASE LIBRE); DE 0,5 A 3,0 G/100 ML DE UN SISTEMA TAMPON CAPAZ DE FIJAR EL PH ENTRE 4 Y 5; DE 0,05 A 0,3 G/100 ML DE UN AGENTE TENSIOACTIVO NO IONICO; DE 0,5 A 2,0 G/100 ML DE UN AGENTE ESPESANTE, Y CSP 100 ML DE AGUA.
ES09501578A 1995-08-03 1995-08-03 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes. Expired - Fee Related ES2106680B1 (es)

Priority Applications (14)

Application Number Priority Date Filing Date Title
ES09501578A ES2106680B1 (es) 1995-08-03 1995-08-03 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
AT96924896T ATE247962T1 (de) 1995-08-03 1996-07-26 Wässrige zusammensetzungen mit ciprofloxacin, verfahren zu deren herstellung und deren verwendung
DE69629664T DE69629664T2 (de) 1995-08-03 1996-07-26 Wässrige zusammensetzungen mit ciprofloxacin, verfahren zu deren herstellung und deren verwendung
JP50814597A JP4081521B2 (ja) 1995-08-03 1996-07-26 シプロフロキサシン含有水性組成物ならびに関連する使用および製法
PT96924896T PT806206E (pt) 1995-08-03 1996-07-26 Composicoes aquosas que contem ciprofloxacina e utilizacao e processo correspondentes
SI9630651T SI0806206T1 (en) 1995-08-03 1996-07-26 Aqueous compositions containing ciprofloxacine, and related use and process
EP96924896A EP0806206B1 (en) 1995-08-03 1996-07-26 Aqueous compositions containing ciprofloxacine, and related use and process
AU65201/96A AU701697B2 (en) 1995-08-03 1996-07-26 Aqueous compositions containing ciprofloxacine, and related use and process
ES96924896T ES2205048T3 (es) 1995-08-03 1996-07-26 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
US08/809,622 US5786363A (en) 1995-08-03 1996-07-26 Aqueous compositions containing ciprofloxacine, and related use
DK96924896T DK0806206T3 (da) 1995-08-03 1996-07-26 Vandige præparater indeholdende ciprofloxacin og tilknyttet anvendelse og fremgangsmåde deraf
RU97107154/14A RU2165755C2 (ru) 1995-08-03 1996-07-26 Композиция для лечения отита среднего уха с перфорацией и способ получения композиции
PCT/ES1996/000155 WO1997005880A1 (es) 1995-08-03 1996-07-26 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes
CA002200760A CA2200760C (en) 1995-08-03 1996-07-26 Aqueous compositions containing ciprofloxacine, and related use and process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501578A ES2106680B1 (es) 1995-08-03 1995-08-03 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.

Publications (2)

Publication Number Publication Date
ES2106680A1 true ES2106680A1 (es) 1997-11-01
ES2106680B1 ES2106680B1 (es) 1998-07-01

Family

ID=8291281

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09501578A Expired - Fee Related ES2106680B1 (es) 1995-08-03 1995-08-03 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
ES96924896T Expired - Lifetime ES2205048T3 (es) 1995-08-03 1996-07-26 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES96924896T Expired - Lifetime ES2205048T3 (es) 1995-08-03 1996-07-26 Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.

Country Status (12)

Country Link
US (1) US5786363A (es)
EP (1) EP0806206B1 (es)
JP (1) JP4081521B2 (es)
AT (1) ATE247962T1 (es)
AU (1) AU701697B2 (es)
CA (1) CA2200760C (es)
DE (1) DE69629664T2 (es)
DK (1) DK0806206T3 (es)
ES (2) ES2106680B1 (es)
PT (1) PT806206E (es)
RU (1) RU2165755C2 (es)
WO (1) WO1997005880A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160090A1 (es) * 2000-03-16 2001-10-16 Vita Invest Sa Composiciones acuosas de ciprofloxacino, contenidas en envases monodosis y su utilizacion.

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101367479B1 (ko) * 2008-07-21 2014-03-14 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 귀 질병 치료를 위한 제어 방출형 항미생물성 조성물 및 방법
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
DK2366408T3 (da) 2010-03-01 2012-10-22 Salvat Lab Sa Vandige, klare opløsninger af fluocinolonacetonid til behandling af inflammation i øret
EP3512513A4 (en) 2016-09-16 2020-04-15 Otonomy, Inc. GEL FORMULA FOR THE EAR FOR TREATING OTITIS EXTERNA
CN112986468B (zh) * 2019-12-13 2024-05-03 武汉九州钰民医药科技有限公司 检测盐酸环丙沙星片中氯代环丙沙星的分析方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
US4957922A (en) * 1985-10-24 1990-09-18 Bayer Aktiengesellschaft Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-di-hydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid
WO1993005816A1 (en) * 1991-09-17 1993-04-01 Alcon Laboratories, Inc. Compositions containing quinolone antibiotics and sulfonate of polystyrol
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957922A (en) * 1985-10-24 1990-09-18 Bayer Aktiengesellschaft Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-di-hydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid
DE3632222A1 (de) * 1986-09-23 1988-04-07 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren
WO1993005816A1 (en) * 1991-09-17 1993-04-01 Alcon Laboratories, Inc. Compositions containing quinolone antibiotics and sulfonate of polystyrol
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160090A1 (es) * 2000-03-16 2001-10-16 Vita Invest Sa Composiciones acuosas de ciprofloxacino, contenidas en envases monodosis y su utilizacion.

Also Published As

Publication number Publication date
DE69629664D1 (de) 2003-10-02
JP4081521B2 (ja) 2008-04-30
ATE247962T1 (de) 2003-09-15
DK0806206T3 (da) 2003-12-08
US5786363A (en) 1998-07-28
EP0806206A1 (en) 1997-11-12
DE69629664T2 (de) 2004-06-24
CA2200760A1 (en) 1997-02-20
PT806206E (pt) 2004-01-30
WO1997005880A1 (es) 1997-02-20
AU6520196A (en) 1997-03-05
JPH11500740A (ja) 1999-01-19
AU701697B2 (en) 1999-02-04
CA2200760C (en) 2007-09-11
ES2205048T3 (es) 2004-05-01
EP0806206B1 (en) 2003-08-27
ES2106680B1 (es) 1998-07-01
RU2165755C2 (ru) 2001-04-27

Similar Documents

Publication Publication Date Title
CY2107B1 (en) Risperidone pamoate
HK1002017A1 (en) Lyospheres comprising gonadotropin
FR2658076B1 (fr) Composition cosmetique contenant des copolymeres d'aminoacides, utile comme agent hydratant.
IL114794A0 (en) Peptidic compounds analogous to distramycin process for their preparation and their use
EP0680694A3 (en) Composition of fluorescent biocides for use in aqueous systems.
TW263499B (es)
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
MA22989A1 (fr) Compositions pour le nettoyage corporel contenant un alcool ethoxyglyceryl sulfonate de sodium.
GR3021680T3 (en) Carpet-cleaning agent
UA6153A1 (uk) Гербіцідна композіція
PL319829A1 (en) Crystallisation of laevobupivacaine and its analoques
ES2106680A1 (es) Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondiente.
GR3003711T3 (es)
BG103306A (en) Liquid allendronate compositions
EP0138616A3 (en) Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them
CA2129921A1 (en) Stable aqueous solutions of hybrid .alpha.-interferon bdbb
TW252979B (es)
DE69609614D1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten
GB8922707D0 (en) New compositions of matter
FR2754824B1 (fr) Nouvelle composition contenant du chitosan
ES8606272A1 (es) Procedimiento para preparar derivados carboxialquildipepti- dicos
HUT53847A (en) Chimney-renewing sprayable composition
IL98852A0 (en) Process for the preparation of sulphinylpristinamycin iib
CA2168769A1 (en) A Process of Cleaning Carpets Using Active Oxygen Compounds in an Acidic Aqueous Medium
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: BAYVIT, S.A.

PC2A Transfer of patent

Owner name: BAYVIT, S.A.

EC2A Search report published

Date of ref document: 19971101

Kind code of ref document: A1

Effective date: 19971101

PC2A Transfer of patent

Free format text: LABORATORIOS LESVI, S.L.

FD2A Announcement of lapse in spain

Effective date: 20151126